What is Integrative Cancer Care?
Cancer Treatments That Saves Lives:
Many patients underestimate how cancer can affect them, physically and emotionally. An integrative approach to cancer care must manage the disease as well as other aspects within it.
Reasonable and proven successful methods may be used in the treatment of each individual case and circumstances to achieve the best possible results.
The overall goal of America Integrative Cancer Care is to provide cancer patients with an effective individualized treatment approach and under the care of professionals in the field.
Q : What is the advantage of America Integrative Cancer Care vs. regular treatments?
A : American Integrative Cancer Care has a world class team of doctors who are well trained in the area of integrative care. Check out some of our patient testimonials here.
Q : Are alternative therapies for cancer better than conventional ones?
A : Alternative therapies alone can delay effective treatment, making the cancerous condition progress into a more advanced and more difficult situation for the patient.
Q : How can get more information about America Integrative Cancer Care's approach to cancer treatments?
A : Contact us here
Universal Treatment Approach for Malignant Solid Tumors:
In most cases, upon diagnosis of a malignant tumor, usually the next step is to refer the patient for surgery, therefore it is the surgeon who makes the first move in the treatment of such malignancy. Following the recovery, the patient then undergoes chemotherapy for several months, at the end of which radiotherapy may be recommended and/or a form of hormone therapy.
The above described sequence of events will likely fail the purpose of eradicating the malignancy, which often recurs either at the original site or distantly or both. Treatment thereafter becomes palliative. At this point the patient has lost the opportunity to free from the grip of the neoplasm.
A precise sequence of steps in medical procedures will yield complete remission, or better yet for the patient, eradication of the disease.
Enter America Integrative Cancer Center.
The malignant tumor reaches far beyond its visible or perceptible confines in the form of microscopic spread, therefore current criteria for safe surgical margins becomes non-operant (unless tumor is at a very early stage or confined to precise limits); it is therefore imperative to focus on eliminating the microscopic spread in anticipation of surgery; for this, a rather low dose of radiation with enhanced biological effect is administered to the tumor, its surroundings and the regional lymphatic areas; the effect of this can be magnified by the use of radio sensitizing agents (of the cytostatic type) administered concomitantly also at low dose; a form of concomitant use of chemotherapy and radiation (CCRT),
The purpose of such preparation also called cyto-reduction or neo-adjuvancy is not to eliminate the tumor, but rather “clear” the surrounding area from the microscopic disease, while at the same time confining the tumor to a smaller mass; this also promotes retraction of the tumor from important structures such as blood vessels, nerves, bone, organs, etc., later on facilitating its removal by a more conservative surgical procedure, thus adhering to the principle of organ/tissue preservation.
Surgery must be precisely timed at the peak effect of the previous cyto-reduction treatment, while at the same time providing the necessary time for the patient’s recovery. Prophylactic use of a cytostatic agent at low dose just before and after the surgical procedure will confer the patient more protection from dissemination of cancerous cells upon surgical manipulation of the tumor; this also helps overlap the time gap between the surgery and the following treatment step.
Consolidation CCRT is administered when patient and wounds recover from surgery (usually 4 – 6 weeks), at which time a smaller dose of radiation (usually half of the previous one) is administered to the same areas in the same fashion, enhanced also by low-dose cytostatic therapy. The objective of this is to eliminate the potential “surgical seeding” and any locally remaining malignant cells.
In addition to the above general approach, other modifications have been implemented to maximize results and minimize side effects. The incorporation of allied modalities has enabled us to overcome well-known resiliencies on some types of malignancies, especially those considered “out of reasonable therapeutic solution”; some of these modalities are not only considered non-toxic but within the realm of supplements.
The above described sequenced treatment approach has been our basis for 30-plus years of practice, and has enabled us to achieve remission in patients, some of who have remained tumor-free for over 10 to 20 years.
Most early stage solid tumor malignancies will enter remission and stay that way for well over 5 years, enough to be considered “eradicated” after using the above general approach. Typically, of this are carcinomas of head & neck, as well as rectal and breast carcinomas. Some others joining the list, and without resorting to surgery, are prostate carcinomas and non-Hodgkin’s lymphomas.
Cancer Patient Criteria:
What we're looking for:
Policy of Promotion: Must be based on track records, achievable results (objective/subjective), type and category of disease, degree and stage, and current status of patient.
Realistic Evaluation/Anticipated Results: We must adhere to conventional/standard diagnostic reports in order to evaluate the patient’s current disease/status and make a rational/realistic treatment plan and anticipated results.
Patient Selection: Patients with malignant solid tumor at any stage that can be treated on out-patient basis programs. No in-hospital cases for treatment.
Immediate Goals: Reduce tumor mass and relieve complications brought out by the disease (pain, dysfunction, impairment, interference with organ/tissue function). Attain demonstrable objective/subjective improvement.
Definitive Goal: Achievement of remission (no clinical evidence of active disease) by means of a planned treatment sequenced approach.
Ultimate Goal: Prolonged remission, as to consider “eradication” of the disease, by follow-up support and methodic long-term monitoring of patient.
Treatment Options: Modified conventional (using radiation, cytostatic, hormonals, surgery, immune-therapy) and Alternative (supplement, supportive, symptomatic).
Synergistic Treatments: The use of a multidisciplinary treatment approach (low-dose radiation/cytostatic, conservative surgery, hormone therapy, immune-therapy, support and supplementation) to minimize possible side-effects and maximize results (see “Universal Treatment Approach for Malignant Solid Tumors”)
Follow-up Policy: Commitment to patient’s treatment/support and monitoring for a minimum of 3 to 5 years, depending on the condition.
Sound like you? Contact us here